Matches in Wikidata for { <http://www.wikidata.org/entity/Q63837006> ?p ?o ?g. }
Showing items 1 to 46 of
46
with 100 items per page.
- Q63837006 description "clinical trial" @default.
- Q63837006 description "ensayu clínicu" @default.
- Q63837006 description "klinisch onderzoek" @default.
- Q63837006 description "клінічне випробування" @default.
- Q63837006 name "Efficacy and Safety in Patients With Type 2 Diabetes Mellitus, Cardiovascular Disease and Hypertension" @default.
- Q63837006 type Item @default.
- Q63837006 label "Efficacy and Safety in Patients With Type 2 Diabetes Mellitus, Cardiovascular Disease and Hypertension" @default.
- Q63837006 prefLabel "Efficacy and Safety in Patients With Type 2 Diabetes Mellitus, Cardiovascular Disease and Hypertension" @default.
- Q63837006 P1050 Q63837006-105EFA72-7EBD-46F5-8721-B474056178D3 @default.
- Q63837006 P1050 Q63837006-C483C775-8664-4E09-9FA8-030D33D97039 @default.
- Q63837006 P1132 Q63837006-8386527A-A356-40B4-8C65-082F3080FA67 @default.
- Q63837006 P1476 Q63837006-1CA94147-2283-40E0-A4AE-B8EB8DE9D783 @default.
- Q63837006 P17 Q63837006-21EFD2DD-D51E-4C40-B617-46D6E16666B3 @default.
- Q63837006 P17 Q63837006-27F767FF-A214-407C-A49D-4A467FA319D8 @default.
- Q63837006 P17 Q63837006-3EAFB046-1AC0-4AB9-95A4-18EEB81F7920 @default.
- Q63837006 P17 Q63837006-93DCEEA2-EEB5-4070-8EF6-53E941D5DC1F @default.
- Q63837006 P17 Q63837006-A2FAD64E-83A1-42BC-8AEB-9D3F3CF0EDE3 @default.
- Q63837006 P17 Q63837006-BDCA0E3D-2DFF-40F7-87E7-880F52507C07 @default.
- Q63837006 P17 Q63837006-D6552992-C60E-4CEC-BCF0-ACBA16907EC0 @default.
- Q63837006 P17 Q63837006-F7EBFF72-41ED-4F28-8306-70B7430E384E @default.
- Q63837006 P2899 Q63837006-65B6349D-6B3A-4293-AB32-7303F7530202 @default.
- Q63837006 P3098 Q63837006-0C46BA3B-0F52-4DD3-98B1-F9BF355574F9 @default.
- Q63837006 P31 Q63837006-8A1474FC-E087-4AFF-A798-C2243F0AF3D7 @default.
- Q63837006 P580 Q63837006-7007FB6C-DE65-4C99-8928-4B6CBDF61805 @default.
- Q63837006 P582 Q63837006-713393FC-8866-40ED-9EF7-580DF34FF17F @default.
- Q63837006 P6099 Q63837006-77174E28-F248-4112-B88A-D6850EFC3228 @default.
- Q63837006 P8363 Q63837006-34536346-5927-4DA2-8C8B-D198B113B3C1 @default.
- Q63837006 P1050 Q12206 @default.
- Q63837006 P1050 Q41861 @default.
- Q63837006 P1132 "+922" @default.
- Q63837006 P1476 "A 24-week, Multicentre, Randomised, Double-blind, Age-stratified, Placebo Controlled, Phase III Study With a 80-week Extension Period to Evaluate the Efficacy and Safety of Dapagliflozin 10 mg Once Daily in Pts With T2DM, CV Disease and Hypertension Who Exhibit Inadequate Glycaemic Control on Usual Care" @default.
- Q63837006 P17 Q16 @default.
- Q63837006 P17 Q183 @default.
- Q63837006 P17 Q214 @default.
- Q63837006 P17 Q218 @default.
- Q63837006 P17 Q29 @default.
- Q63837006 P17 Q414 @default.
- Q63837006 P17 Q865 @default.
- Q63837006 P17 Q881 @default.
- Q63837006 P2899 "+45" @default.
- Q63837006 P3098 "NCT01031680" @default.
- Q63837006 P31 Q30612 @default.
- Q63837006 P580 "2010-02-01T00:00:00Z" @default.
- Q63837006 P582 "2011-05-01T00:00:00Z" @default.
- Q63837006 P6099 Q42824827 @default.
- Q63837006 P8363 Q78089383 @default.